Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Gracell Biotechnologies Inc. (NASDAQ: GRCL) announced participation in two investor conferences. The Piper Sandler 34th Annual Healthcare Conference will take place on November 30, featuring a presentation at 4:00 pm ET and one-on-one meetings. The JMP Securities Hematology & Oncology Summit is scheduled for December 7 with a presentation at 10:00 am ET. Both events aim to enhance Gracell's outreach in the biopharmaceutical sector. A webcast of the chat will be available for 30 days post-event on their investor website.

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Nov. 23, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at two upcoming investor conferences.

Piper Sandler 34^th Annual Healthcare Conference
Presentation: November 30^th at 4:00 pm ET
One-on-one meetings: Wednesday, November 30, 2022
Location: New York, NY

JMP Securities Hematology & Oncology Summit (virtual)
Presentation: December 7^th at 10:00 am ET
One-on-one meetings: December 6 - 7, 2022

Webcast of the fireside chat will be available on the News and Events section of Gracell's investor website. A replay of the webcast will be available for 30 days following the event.

About Gracell

Gracell Biotechnologies Inc. ("Gracell") is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms and SMART CART^TM technology module, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost and lack of effective CAR-T therapies for solid tumors. For more information on Gracell, please visit www.gracellbio.com. Follow @GracellBio on LinkedIn.

Media contact
Marvin Tang
marvin.tang@gracellbio.com

Investor contact
Gracie Tong 
gracie.tong@gracellbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gracell-biotechnologies-to-participate-in-two-upcoming-investor-conferences-301685858.html

SOURCE Gracell Biotechnologies Inc.

FAQ

What is Gracell Biotechnologies' upcoming conference schedule?

Gracell will present at the Piper Sandler 34th Annual Healthcare Conference on November 30 at 4:00 pm ET, and the JMP Securities Hematology & Oncology Summit on December 7 at 10:00 am ET.

When are the one-on-one meetings for Gracell at the investor conferences?

One-on-one meetings for Gracell are scheduled for November 30 for the Piper Sandler Conference and December 6-7 for the JMP Securities Summit.

Where will Gracell's presentations take place?

The Piper Sandler Conference will be held in New York, NY, while the JMP Securities Summit will be a virtual event.

How can I access Gracell's conference webcasts?

Webcasts of Gracell's presentations will be available in the News and Events section of their investor website for 30 days following each event.